Effect of Roux-en-Y gastric bypass on pharmacologic dependence in obese patients with type 2 diabetes
Conclusion: Roux-en-Y gastric bypass resulted in significant improvement in diabetic control, with a reduction in hypoglycemic medication use and associated costs in the early postoperative period. Potentially, large indirect and direct cost savings can be realized in the longer term.
PMID: 31348633 [PubMed - as supplied by publisher]
Source: Canadian Journal of Surgery - Category: Surgery Authors: Sharples AJQ, Mullan M, Hardy K, Vergis A Tags: Can J Surg Source Type: research
More News: Bariatric Surgery | Canada Health | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Gastric Bypass | Gastroenterology | Health Management | Insulin | Obesity | Surgery | Weight Loss